Stockreport

Theratechnologies Announces New Positive Results for two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer

Theratechnologies Inc. - Common Shares  (THTX) 
PDF TH1902 and TH1904 more effective and safer in vivo compared to current standard ovarian cancer treatments New data presented during the AACR Virtual Annual Meeting [Read more]